Clinical Trial Update: Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial [NA]

View source ↗

Summary

Clinical trial CARMA evaluating aggressive cardiac risk mitigation in thoracic radiotherapy has completed. The sponsor is Cedars-Sinai Medical Center, and the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Cancer | NA | Status: COMPLETED